Cargando…

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858826/
https://www.ncbi.nlm.nih.gov/pubmed/29589598
http://dx.doi.org/10.2147/BCTT.S166117
_version_ 1783307717072388096
collection PubMed
description
format Online
Article
Text
id pubmed-5858826
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58588262018-03-27 Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum] Breast Cancer (Dove Med Press) Corrigendum Dove Medical Press 2018-03-16 /pmc/articles/PMC5858826/ /pubmed/29589598 http://dx.doi.org/10.2147/BCTT.S166117 Text en © 2018 Criscitiello et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Corrigendum
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_full Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_fullStr Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_full_unstemmed Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_short Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_sort profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [corrigendum]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858826/
https://www.ncbi.nlm.nih.gov/pubmed/29589598
http://dx.doi.org/10.2147/BCTT.S166117